Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06974305

PET/MRI/EEG Imaging Study in Epilepsy

Investigation of Interictal Metabolic and Electrophysiologic Changes in Epilepsy Through Trimodal Neuroimaging

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aims to better understand how epilepsy alters brain function through neuroimaging of healthy people and people with epilepsy. The study investigates how changes in brain metabolism (sugar consumption, measured by positron emission tomography \[FDG-PET\], and blood flow, measured by functional magnetic resonance imaging \[fMRI\]) relate to abnormal interictal electrical activity associated with epilepsy (measured by electroencephalography \[EEG\]). The study will also compare how the three imaging modalities localize regions of abnormal function in the brain.

Conditions

Interventions

TypeNameDescription
RADIATIONFDG-PET/fMRI/EEG imagingSubject will undergo simultaneous EEG, fMRI, and FDG-PET imaging. This includes the use of a standard injected radioactive marker used in PET imaging.

Timeline

Start date
2023-09-21
Primary completion
2025-11-30
Completion
2025-11-30
First posted
2025-05-15
Last updated
2025-05-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06974305. Inclusion in this directory is not an endorsement.